What level of thyroglobulin predicts cancer recurrence?
Australian study suggests more patients are at low risk than current advice suggests
Doctors could use a cut-off level of 2ng/mL for stimulated thyroglobulin to determine which patients with papillary thyroid cancer are more likely to have post-op recurrence, Australian researchers say.
The Sydney-based team examined data for 502 patients who had undergone total thyroidectomy followed by radioactive iodine ablation for papillary tumours of 1cm or more in diameter between 2000 and 2016.
